Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-03-13
1999-09-21
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514569, 514428, 514416, 514375, A61K 3119, A61K 3140, A61K 3142
Patent
active
059555041
ABSTRACT:
A composition for use in preventing colorectal cancer and other neoplastic diseases includes an enantiomerically stable R-NSAID or a pharmaceutically acceptable salt thereof in an amount effective to elicit a chemoprotective effect. The composition is substantially free of the S-enantiomer of the R-NSAID. Therapeutic use of the composition is accompanied by reduced adverse side effects.
REFERENCES:
patent: 3755427 (1973-08-01), Adams et al.
patent: 4983765 (1991-01-01), Lukas et al.
patent: 5200198 (1993-04-01), Geisslinger et al.
patent: 5206029 (1993-04-01), Brune et al.
patent: 5331000 (1994-07-01), Young et al.
patent: 5382591 (1995-01-01), Barberich et al.
patent: 5560924 (1996-10-01), Wunderlich et al.
Hixson et al, Cancer Epidemial, Biomaukeu Prev. (1994) 3(5), 433-8 Abstract Only.
Menzel-Soglowek et al. Agent S T Action, Suddle (1993) 44 23-9 (Abstract Only-original reference to follow in due course.
W.J. Wechter: "Drug Chirality: On the Mechanism of R-Aryl Propionic Acid Class NSAIDs. Epimerization in Humans and the Clinical Implications for the Use of Racemates." J. Clin. Pharmacol., vol. 34, No. 11, 1994, pp. 1036-1042.
W.J. Wechter: "Rac-Flurbiprofen is More Ulcerogenic than its (s)-Enantiomer." Chirality, vol. 5, No. 7, 1993 pp. 492-494.
Moertel, et al., "Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma," N Engl J Med 1990; 322:352-8.
Heath, et al., "Nonsteroidal Antiinflammatory Drugs and Human Cancer," Cancer, 1994; 74:2885-8.
Marnett, "Aspirin and the Potential Role of Prostaglandins in Colon Cancer," Cancer Research, 1992; 52:5575-89.
Welberg et al., "Proliferation Rate of Colonic Mucosa in Normal Subjects and Patients with Colonic Neoplasms: A Refined Immunohistochemical Method," J Clin Pathol, 1990; 43:453-456.
Thun et al., "Aspirin Use and Reduced Risk of Fatal Colon Cancer," N Engl J Med 1991; 325:1593-6.
Peleg, et al., "Aspirin and Nonsteroidal Anti-inflammatory Drug Use and the Risk of Subsequent Colorectal Cancer," Arch Intern Med. 1994, 154:394-399.
Gridley, et al., "Incidence of Cancer among Patients With Rheumatoid Arthritis" J. Natl Cancer Inst 1993 85:307-311.
Labayle, et al., "Sulindac Causes Regression Of Rectal Polyps In Familial Adenomatous Polyposis" Gastroenterology 1991 101:635-639.
Rigau, et al., "Effects Of Long-Term Sulindac Therapy On Colonic Polyposis" Annals of Internal Medicine 1991 115:952-954.
Giardiello,et al., "Treatment Of Colonic and Rectal Adenomas With Sulindac In Familial Adenomatous Polyposis" N Engl J. Med 1993:328:1313-6.
Pollard, et al., "Effect Of Indomethacin On Intestinal Tumors Induced In Rats By The Acetate Derivative Of Dimethylnitrosamine" Oct. 30, 1981 Science, vol. 214, pp. 558-559.
Reddy, et al., "Inhibitory Effect Of Aspirin On Azoxymethane-Induced Colon Carcinogenesis In F344 Rats" 1993 Carcinogenesis, vol. 14, No. 8 1493-1497.
Gibaldi et al., Pharmacokinetics, 1982, Chapter 1, pp. 1-5.
Jamali, "Pharmacokinetics of Enantiomers of Chiral Non-steroidal Anti-inflammatory Drugs," Eur. J. Drug Metab. Pharmacokin., 1988, vol. 13, No. 1, pp. 1-9.
Waterhouse, et al., "Aspirin, NSAIDs, and Risk Reduction of Colorectal Cancer", Arch Intern Med, vol. 154, Feb. 28, 1994, pp. 366-368.
Lipkin, "Biomakers of Increased Susceptibility to Gastrointestinal Cancer: New Application to Studies of Cancer Prevention in Human Subjects", Cancer Research 48, Jan. 15, 1988, pp. 235-245.
McCracken John D.
Wechter William J.
Goldberg Jerome D.
Loma Linda University Medical Center
LandOfFree
Colorectal chemoprotective composition and method of preventing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Colorectal chemoprotective composition and method of preventing , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colorectal chemoprotective composition and method of preventing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-80811